Peptide therapy on TikTok: separating hype from human data

What did @thevaultedstudio actually say?

The creator, a self-described 48-year-old former competitive powerlifter with 70 competitions under his belt, says BPC-157 is now part of his regular routine. His pitch is personal: years of heavy lifting, multiple surgeries, and chronic shoulder issues led him to what he calls the "Wolverine stack." He rates BPC-157 as "S tier" for injury prevention and recovery, saying it can benefit anyone who wants to "prevent injuries, feel better, and get back to the gym."

That's a credible framing, honestly. He's not claiming BPC-157 cured a disease or reversed a diagnosis. He's describing a personal use case that fits the most common reason people explore this peptide. The shoulder context matters. The power-lifting background gives it some texture. Still, personal experience isn't a clinical trial, and "S tier" is a vibe, not a data point.

Does the science back this up?

Sort of, but with significant caveats. The honest answer is that BPC-157's evidence base is mostly preclinical, meaning rodent studies, and extrapolating from rats to a 48-year-old human shoulder is a real stretch.

BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from a protein found in gastric juice. In animal models, it has shown pro-angiogenic and tendon-healing effects. A frequently cited study by Pevec et al. (2010, Journal of Orthopaedic Research) found that BPC-157 accelerated Achilles tendon healing in rats. Chang et al. (2011, Journal of Applied Physiology) showed improved muscle healing after transection injuries in rodents. These are genuinely interesting findings.

The problem is that no randomized controlled trials in humans have confirmed these effects. The FDA has not approved BPC-157 for any indication. The Peptide Society's own position acknowledges the gap between animal data and human clinical evidence. So the science is intriguing but nowhere near settled for human musculoskeletal recovery.

What did they get wrong (or right)?

He got the framing right: BPC-157 is a reasonable candidate for someone with chronic musculoskeletal wear, based on the existing mechanistic and animal data. He did not overclaim a cure, did not name a specific dose, and did not promise results. That's more restrained than a lot of peptide content on this platform.

What he got fuzzy is the "S tier" designation without any acknowledgment that the human evidence is essentially nonexistent. Calling something S tier in a vacuum implies a level of certainty the literature does not support. A systematic review by Kim et al. (2023, Frontiers in Pharmacology) noted that while BPC-157 shows consistent results in animal healing models, human pharmacokinetic data is sparse and safety data in long-term human use is not well characterized.

He also uses the term "Wolverine stack" without explaining what else is in it. Stacking peptides without clinical guidance carries compounding unknowns, and casual audiences may not grasp that.

What should you actually know?

BPC-157 is not FDA-approved and is considered an investigational compound. It is currently available in the US only through compounding pharmacies when prescribed by a licensed provider, and its regulatory status has been under increased FDA scrutiny since 2023 when the agency moved to restrict certain peptides from compounding.

If you are someone with a legitimate injury history and are curious about peptide therapy, that conversation belongs with a licensed clinician who can review your individual history, imaging, and health status. A compelling TikTok from someone with a cookbook is not a substitute for that. The preclinical data on tendon and soft tissue repair is real enough to be worth discussing with a provider. It is not real enough to self-prescribe based on a social media recommendation.

The "feel better and get back to the gym" framing also papers over the fact that inflammation and pain sometimes serve a protective function during healing. Using any compound to push through injury recovery faster than your tissue can actually repair carries its own risks.